Study finds racial and gender differences in HIV drug side effects
Certain HIV drug side effects are more pronounced in African Americans and women, Temple University School of Medicine researchers reported in one of the first clinical trials of HIV drug therapy to include significant numbers of racial and ethnic minorities and women.
|
“The populations impacted most by HIV in the U.S. are African American and Latino, groups known to have healthcare disparities overall; for example, higher rates of hypertension, cardiovascular and kidney disease,” said Tedaldi, professor of medicine and director of the Comprehensive HIV Program at Temple.
When physicians understand HIV drug therapy risks and effects, they can choose the best course of treatment for diverse populations. For example, psychiatric problems can have significant effects over the long term on adherence to HIV drug therapy as well as on medical outcomes.
The findings from the study are published in the April 2008 issue of the Journal of Acquired Immune Deficiency Syndrome. |
![]() Ellen Tedaldi, M.D., professor of medicine and director of the Comprehensive HIV Program, Temple University School of Medicine and Hospital
|
“Overall, this study recognizes the vulnerabilities of particular populations with HIV,” Tedaldi said. “We need to try to get HIV patients identified sooner to minimize these adverse events and to work on the other health disparate conditions to prevent the long term complications of cardiovascular and renal disease.” The National Institute of Allergy and Infectious Diseases at the National Institutes of |